Home › Device types › JTN
Susceptibility Test Discs, Antimicrobial
FDA product code JTN · Class 2 · Microbiology
361
Registered devices
35
Adverse events
47
Recalls
331
510(k) clearances
Devices with this code
BD BBL™ Sensi-Disc™ Rifampin 5 µg — BECTON, DICKINSON AND COMPANYOxoid Eravacycline Disc (20ug) ERV20 Antimicrobial Susceptibility Test Discs — OXOID LIMITEDBD BBL™ Sensi-Disc™ Ethionamide - 25 µg — BECTON, DICKINSON AND COMPANYHardyDisk™ — HARDY DIAGNOSTICSHardyDisk™ — HARDY DIAGNOSTICSOxoid Lefamulin (20ug) LMU20 Antimicrobial Susceptibility Test Discs — OXOID LIMITEDBD BBL™ Sensi-Disc™ Cephalothin - 30 µg — BECTON, DICKINSON AND COMPANYBD BBL™ Sensi-Disc™ Triple Sulfa - 0.25 mg — BECTON, DICKINSON AND COMPANYBD BBL™ Sensi-Disc™ Meropenem 10 µg — BECTON, DICKINSON AND COMPANYBD BBL™ Sensi-Disc™ Colistin 10 µg — BECTON, DICKINSON AND COMPANYNA — OXOID LIMITEDHardyDisk™ — HARDY DIAGNOSTICSBD BBL™ Sensi-Disc™ Azlocillin - 75 µg — BECTON, DICKINSON AND COMPANYBD BBL™ Sensi-Disc™ Erythromycin - 2 µg — BECTON, DICKINSON AND COMPANYNA — OXOID LIMITEDNA — OXOID LIMITEDBD BBL™ Sensi-Disc™ Vancomycin 5 µg — BECTON, DICKINSON AND COMPANYBD BBL™ Sensi-Disc™ P-Aminosalicylic Acid - 10 µg — BECTON, DICKINSON AND COMPANYHardyDisk™ — HARDY DIAGNOSTICSNA — OXOID LIMITEDNA — OXOID LIMITEDBD BBL™ Sensi-Disc™ Gentamicin 10 µg — BECTON, DICKINSON AND COMPANYBD BBL™ Sensi-Disc™ Tetracycline 30 µg — BECTON, DICKINSON AND COMPANYHardyDisk™ — HARDY DIAGNOSTICS
Recent recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-06-08 | Hardy Diagnostics | Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lea |
| 2024-12-23 | Oxoid Limited | Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs. |
| 2024-11-06 | Becton Dickinson & Co. | BD identified through potency testing as part of a stability test request to monitor Ampicillin AM-2 due to decrease in potency results of 65% at 18 months, may |
| 2024-01-08 | Becton Dickinson & Co. | There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product dis |
| 2024-01-08 | Becton Dickinson & Co. | There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product dis |
| 2024-01-08 | Becton Dickinson & Co. | There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product dis |
| 2024-01-08 | Becton Dickinson & Co. | There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product dis |
| 2024-01-08 | Becton Dickinson & Co. | There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product dis |
| 2024-01-08 | Becton Dickinson & Co. | There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product dis |
| 2024-01-08 | Becton Dickinson & Co. | There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product dis |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsSourced from public U.S. FDA data. Informational only — not medical or regulatory advice. Not affiliated with the FDA.